News Lilly and Boehringer biosimilar undercuts Lantus by 15% Sanofi under pressure following long-awaited biosimilar launch.
News Five UK pharma companies "named and shamed" by watchdog Companies' actions discredited the industry, says PMCPA.
News Lilly/Boehringer's long-acting diabetes pill approved in US Long-release pill is eighth drug to come from diabetes partnership.
News Lilly and AZ begin new Alzheimer's tie-up Companies to develop MEDI1814, building on existing collaboration.
News Lilly's Lartruvo approved in US for soft tissue sarcoma Eli Lilly’s 'breakthrough' drug for soft tissue sarcoma, Lartruvo, has been approved by the FDA.
News Ipsen' Bylvay fluffs its lines in biliary atresia trial Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
